Inversion is the gift that keeps on giving for Actavis. Last year the pharmaceutical company reincorporated from its Parsipanny, New Jersey, home to Ireland, after a $5 billion deal with Warner Chilcotte. This year, before Treasury’s inversion curbs took effect, it purchased New York-based Forest
The Department of Energy snookered the media last week with a report that seems to show that its clean energy lending programs are profitable. “ Remember Solyndra? Those loans are making money ,” went a typical headline. Unfortunately, that’s not true. Taxpayers are losing money on DOE lending.